• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALUNG TECHNOLOGIES, INC. HEMOLUNG RAS; EXTRACORPOREAL SYSTEM FOR CARBON DIOXIDE REMOVAL FOR THE TREATMENT OF COVID-19

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALUNG TECHNOLOGIES, INC. HEMOLUNG RAS; EXTRACORPOREAL SYSTEM FOR CARBON DIOXIDE REMOVAL FOR THE TREATMENT OF COVID-19 Back to Search Results
Model Number HL-CR4-01-000
Device Problem Defective Component (2292)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/25/2020
Event Type  malfunction  
Manufacturer Narrative
Alung technologies, inc.Manufactures the hemolung ras and catheter.The incident occurred in stevenage, united kingdom.It was reported that during therapy, staff experienced a critical 102 error.The controller responded appropriately by stopping the blood pump.Customer service was provided in which they advised to disconnect the o2, restart the controller, and evaluate the circuit.However, after inspecting the circuit, the physician felt it was unsafe to attempt to restart therapy.Customer support was provided through ending therapy.The patient was assessed the following day and the site staff confirmed the patient was seemingly unaffected by the issue with the control.Following the discontinuation of therapy, a replacement controller was installed and testing without issue.Site staff was satisfied with the support provided and the equipment replacement.The removed cr4 controller was returned to avensys for repair.Through review of the data log, it was determined that there was a leak from the oxygen sweep gas.This controller was recertified, with tubings replaced, and passed all testing without issue.The data log from therapy has been retrieved and reviewed by both clinical and software engineering staff.No abnormalities were noted within the co2 removal and blood flow graphs.Therapy was provided as intended.Site staff was satisfied with the support provided and there were no clinical complications reported as to have occurred as a result of the alarm.No capa was opened because of this event.Examination of the controller data log shows that therapy was provided as intended.Alung technologies, inc.Will continue to monitor any issues as they are reported.This mdr is being filed in response to a retrospective view of all alung technologies, inc.Complaints, which identified that the reporting decision for this complaint was not correct.This mdr is being filed retrospectively to correct the error in the reporting decision.
 
Event Description
Alung technologies, inc.Received a report that during eua hemolung therapy, staff experienced a critical 102 error.The controller responded appropriately by stopping the blood pump.Customer service was provided in which they advised to disconnect the o2, restart the controller, and evaluate the circuit.However, after inspecting the circuit, the physician felt it was unsafe to attempt to restart therapy.Customer support was provided through ending therapy.The patient was assessed the following day and the site staff confirmed the patient was seemingly unaffected by the issue with the control.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEMOLUNG RAS
Type of Device
EXTRACORPOREAL SYSTEM FOR CARBON DIOXIDE REMOVAL FOR THE TREATMENT OF COVID-19
Manufacturer (Section D)
ALUNG TECHNOLOGIES, INC.
2500 jane st
suite 1
pittsburgh PA 15203
Manufacturer Contact
ryan coyle
2500 jane st
suite 1
pittsburgh, PA 15203
MDR Report Key16211821
MDR Text Key308767596
Report Number3009763347-2023-00074
Device Sequence Number1
Product Code QLN
UDI-Device Identifier00850046004346
UDI-Public(01)00850046004346(17)180502
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
DEN210006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Remedial Action Repair
Type of Report Initial
Report Date 01/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/19/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberHL-CR4-01-000
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/25/2020
Was Device Evaluated by Manufacturer? No
Date Device Manufactured05/02/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient SexFemale
-
-